PAVmed shareholders approve reverse stock split (1:10–1:30) and authorized share reduction to 25M

PAVmed Inc.

Stockholders approved reverse split (ratio 1:10–1:30, board to decide) and authorized share reduction from 250M to 25M.
Vote: 19,310,685 For, 974,164 Against, 13,241 Abstain; 65.8% of voting power present at Dec 5 special meeting.
Board expects to file certificate of amendment with Delaware Secretary of State as soon as practicable.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.